Autolus Therapeutics (AUTL) Capital Expenditures (2018 - 2025)
Autolus Therapeutics' (AUTL) quarterly Capital Expenditures came in at -$885000.0 in Q4 2025, down 107.96% YoY from $11.1 million in Q4 2024, and down 120.08% on a QoQ basis from $4.4 million in Q3 2025.
Autolus Therapeutics (AUTL) Capital Expenditures (2018 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has 8 years of Capital Expenditures data on file, last reported at -$885000.0 in Q4 2025.
- Quarterly Capital Expenditures fell 107.96% year-over-year to -$885000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $19.0 million (down 13.73% YoY) and the FY2025 annual result came in at $19.0 million, down 13.73% from the prior year.
- Capital Expenditures declined to -$885000.0 in Q4 2025, from $4.4 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $11.1 million in Q4 2024 to a low of -$885000.0 in Q4 2025.
- A 5-year average of $3.6 million and a median of $2.8 million in 2021 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 1385.23% in 2025, down 107.96% in 2025.
- Tracing AUTL's Capital Expenditures over 5 years: stood at $1.6 million in 2021, then slumped by 60.06% to $633000.0 in 2022, then soared by 133.33% to $1.5 million in 2023, then surged by 652.34% to $11.1 million in 2024, then sank by 107.96% to -$885000.0 in 2025.
- The last three Capital Expenditures figures came in at -$885000.0 (Q4 2025), $4.4 million (Q3 2025), and $7.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -885,000.00 |
| Dec 31, 2025 | -885,000.00 |
| Sep 30, 2025 | 4.41 Mn |
| Sep 30, 2025 | 4.41 Mn |
| Jun 30, 2025 | 7.28 Mn |
| Jun 30, 2025 | 7.28 Mn |
| Mar 31, 2025 | 8.24 Mn |
| Mar 31, 2025 | 8.24 Mn |
| Dec 31, 2024 | 11.11 Mn |
| Dec 31, 2024 | 11.11 Mn |
| Sep 30, 2024 | 9.59 Mn |
| Sep 30, 2024 | 9.59 Mn |
| Jun 30, 2024 | 819,000.00 |
| Jun 30, 2024 | 819,000.00 |
| Mar 31, 2024 | 555,000.00 |
| Mar 31, 2024 | 555,000.00 |
| Dec 31, 2023 | 1.48 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Sep 30, 2023 | 1.50 Mn |
| Sep 30, 2023 | 1.50 Mn |